Estrogen receptor variant ER‐α36 promotes tamoxifen agonist activity in glioblastoma cells

Glioblastoma (GBM) is a highly infiltrative and malignant primary brain tumor. Despite aggressive therapy, patients with GBM have a dismal prognosis with median survival of approximately 1 year. Tamoxifen (TAM), a selective estrogen receptor modulator (SERM), has been used to treat GBM for many year...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Chao, Ma, Jingyun, Zhang, Yejun, Han, Chao, Huang, Liang, Shen, Liming, Li, Hongyan, Wang, Xiaobo, Liu, Jing, Zou, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317923/
https://www.ncbi.nlm.nih.gov/pubmed/30417588
http://dx.doi.org/10.1111/cas.13868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317923/
https://www.ncbi.nlm.nih.gov/pubmed/30417588
http://dx.doi.org/10.1111/cas.13868

Ejemplares similares